Nicholas Mongillo
Adolescent Medicine · Shelton, CTNPI 1073536710
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Corium, LLC at 25.2% of the total. Reporting peaked in 2023 at $575 and has fallen 52.2% since, to $275 in 2025. Among adolescent medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$493
- Tris Pharma Inc$473
- Ironshore Pharmaceuticals Inc.$174
- Merck$117
- Sanofi Pasteur Inc.$110
- Supernus Pharmaceuticals, Inc.$89
- plus $503 from 12 others
What the payments were for
- Food & beverage$1,960100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 19 | $493 |
| Tris Pharma Inc | 32 | $473 |
| Ironshore Pharmaceuticals Inc. | 8 | $174 |
| Merck | 7 | $117 |
| Sanofi Pasteur Inc. | 6 | $110 |
| Supernus Pharmaceuticals, Inc. | 5 | $89 |
| GSK | 4 | $80 |
| Vertical Pharmaceuticals, LLC | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Kaleo, Inc. | 3 | $64 |
| Neos Therapeutics, LP | 3 | $48 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Adlon Therapeutics L.p. | 1 | $25 |
| Alk-abello, Inc | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| Pfizer | 1 | $21 |
| Shire North American Group Inc | 1 | $14 |
| Rhodes Pharmaceuticals L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$125
How this compares
$1,960 in reported general payments places this provider in the 90th percentile of 57 adolescent medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 12 | $281 |
| Chlorhexidine Gluconate | 13 | $165 |
Paid to pharmacies, not to this prescriber.
Other adolescent medicine in Shelton
- Fadi HammoudShelton$2K
- Christa JohnsonShelton$954
- Michelle RivelliShelton$818
- Melanie GeorgalasShelton$697
- Karen LaugelShelton$13
- Husam ShitiaCheshire$7K
- David SchwindtMystic$5K
- Ramani YapaHamden$4K
- Hikmat ShaarbafWallingford$2K
- Debbie CayabyabWaterbury$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.